Pacira Pharmaceuticals buy Needham & Company LLC
Start price
02.07.24
/
50%
€21.20
Target price
02.07.25
€40.02
Performance (%)
-28.77%
Price
03.10.24
€14.10
Summary
This prediction is currently active. The prediction for Pacira Pharmaceuticals disappoints with a performance of -28.77%. This prediction currently runs until 02.07.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 9.302% | 9.302% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Needham___Company_LL for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $43.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€19.40
31.07.24
31.07.24
€39.65
31.07.25
31.07.25
-22.16%
03.10.24
03.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.60
08.05.24
08.05.24
€39.99
08.05.25
08.05.25
-47.37%
03.10.24
03.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€25.80
09.04.24
09.04.24
€41.35
09.04.25
09.04.25
-45.74%
03.10.24
03.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
01.03.24
01.03.24
€41.61
01.03.25
01.03.25
-47.76%
03.10.24
03.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€33.40
03.08.23
03.08.23
€47.53
03.08.24
03.08.24
-44.91%
04.08.24
04.08.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€41.00
20.04.23
20.04.23
€54.71
20.04.24
20.04.24
-40.98%
21.04.24
21.04.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€40.40
28.02.23
28.02.23
€56.63
28.02.24
28.02.24
-32.18%
29.02.24
29.02.24